Pivotal VALIANT results presented at Kidney Week show pegcetacoplan treatment effect in patients with C3G / primary IC-MPGN

Statistically significant 68% (p<0.0001) proteinuria reduction compared to placebo, with reduction observed as early as Week 4 All secondary endpoints

READ MORE

Implantica announces finalization of remarkable 5-year pivotal CE mark study results and gears up for the Module 2 submission of PMA application to FDA for RefluxStop™

Implantica AG (publ.), a medtech company at the forefront of introducing advanced technology into the body, including a unique device

READ MORE

India Water Sustainability Forum, Launched by SoulAce, Highlights Pivotal Role of CSR in Water Security

Water is at the core of sustainable development, critical for the survival of humanity and the planet. As part of the Sustainable Development Goals (SDGs),

READ MORE